Clinical trial
Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures
NCT00250302 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Autologous Implantation of Mesenchymal Stem Cells for the Treatment of Distal Tibial Fractures
- Lead sponsor
- Hadassah Medical Organization
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- April 30, 2009
- Completion date
- April 30, 2011
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tibial fracture